62 related articles for article (PubMed ID: 17458114)
1. [Control of activation of a cell adhesion molecule, integrin].
Shimaoka M
Masui; 2006 Nov; 55 Suppl():S24-33. PubMed ID: 17458114
[No Abstract] [Full Text] [Related]
2. Activation of leukocyte beta2 integrins by conversion from bent to extended conformations.
Nishida N; Xie C; Shimaoka M; Cheng Y; Walz T; Springer TA
Immunity; 2006 Oct; 25(4):583-94. PubMed ID: 17045822
[TBL] [Abstract][Full Text] [Related]
3. A catch to integrin activation.
McEver RP; Zhu C
Nat Immunol; 2007 Oct; 8(10):1035-7. PubMed ID: 17878912
[No Abstract] [Full Text] [Related]
4. Alpha-4/beta-1 and alpha-L/beta-2 integrins mediate cytokine induced lung leukocyte-epithelial adhesion and injury.
Parmley LA; Elkins ND; Fini MA; Liu YE; Repine JE; Wright RM
Br J Pharmacol; 2007 Nov; 152(6):915-29. PubMed ID: 17828290
[TBL] [Abstract][Full Text] [Related]
5. Small GTPases and LFA-1 reciprocally modulate adhesion and signaling.
Mor A; Dustin ML; Philips MR
Immunol Rev; 2007 Aug; 218():114-25. PubMed ID: 17624948
[TBL] [Abstract][Full Text] [Related]
6. Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa is mandatory for TCR-mediated inside-out signaling, but dispensable for CXCR4-mediated LFA-1 activation, adhesion, and migration of T cells.
Horn J; Wang X; Reichardt P; Stradal TE; Warnecke N; Simeoni L; Gunzer M; Yablonski D; Schraven B; Kliche S
J Immunol; 2009 Nov; 183(9):5756-67. PubMed ID: 19812192
[TBL] [Abstract][Full Text] [Related]
7. Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases.
Smith DJ; Vainio PJ
Ann N Y Acad Sci; 2007 Sep; 1110():382-8. PubMed ID: 17911453
[TBL] [Abstract][Full Text] [Related]
8. Guanine nucleotide-binding proteins of the G12 family shape immune functions by controlling CD4+ T cell adhesiveness and motility.
Herroeder S; Reichardt P; Sassmann A; Zimmermann B; Jaeneke D; Hoeckner J; Hollmann MW; Fischer KD; Vogt S; Grosse R; Hogg N; Gunzer M; Offermanns S; Wettschureck N
Immunity; 2009 May; 30(5):708-20. PubMed ID: 19409815
[TBL] [Abstract][Full Text] [Related]
9. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
Chin LT; Chu C; Chen HM; Wang DW; Liao SK
Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
[TBL] [Abstract][Full Text] [Related]
10. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces.
Woolf E; Grigorova I; Sagiv A; Grabovsky V; Feigelson SW; Shulman Z; Hartmann T; Sixt M; Cyster JG; Alon R
Nat Immunol; 2007 Oct; 8(10):1076-85. PubMed ID: 17721537
[TBL] [Abstract][Full Text] [Related]
11. Sequence recognition of alpha-LFA-1-derived peptides by ICAM-1 cell receptors: inhibitors of T-cell adhesion.
Yusuf-Makagiansar H; Yakovleva TV; Tejo BA; Jones K; Hu Y; Verkhivker GM; Audus KL; Siahaan TJ
Chem Biol Drug Des; 2007 Sep; 70(3):237-46. PubMed ID: 17718718
[TBL] [Abstract][Full Text] [Related]
12. Regulation of integrin activation through the B-cell receptor.
Arana E; Harwood NE; Batista FD
J Cell Sci; 2008 Jul; 121(Pt 14):2279-86. PubMed ID: 18596256
[TBL] [Abstract][Full Text] [Related]
13. The importance of prolonged binding to antigen-presenting cells for T cell fate decisions.
Engelhardt JJ; Krummel MF
Immunity; 2008 Feb; 28(2):143-5. PubMed ID: 18275826
[TBL] [Abstract][Full Text] [Related]
14. Macromolecular immunosuppressants.
Dingermann T; Zündorf I
Biotechnol J; 2006 Jan; 1(1):47-57. PubMed ID: 16892224
[TBL] [Abstract][Full Text] [Related]
15. Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins.
Simeoni L; Lindquist JA; Smida M; Witte V; Arndt B; Schraven B
Immunol Rev; 2008 Aug; 224():215-28. PubMed ID: 18759929
[TBL] [Abstract][Full Text] [Related]
16. [IL-6 as a target in autoimmune disease and inflammation].
Hashizume M; Ohsugi Y
Nihon Yakurigaku Zasshi; 2014 Oct; 144(4):172-7. PubMed ID: 25312286
[No Abstract] [Full Text] [Related]
17. DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders.
Elishmereni M; Bachelet I; Levi-Schaffer F
Curr Opin Investig Drugs; 2008 May; 9(5):491-6. PubMed ID: 18465659
[TBL] [Abstract][Full Text] [Related]
18. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis.
Munroe ME
Semin Immunol; 2009 Oct; 21(5):283-8. PubMed ID: 19539498
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphocyte function associated antigen 1 by LFA878 induces apoptosis in multiple myeloma cells and is associated with downregulation of the focal adhesion kinase/phosphatidylinositol 3 kinase/Akt pathway.
Schmidmaier R; Mandl-Weber S; Gaul L; Baumann P; Bumeder I; Straka C; Emmerich B
Int J Oncol; 2007 Oct; 31(4):969-76. PubMed ID: 17786331
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 as a drug target in human disease.
Ivanov S; Lindén A
Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
